🔎 Trials Near Me

Akèy › Timò Nèwo-endokrin › Texas › Houston

Etid klinik pou Timò Nèwo-endokrin nan Houston, TX

8 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Ap rekriteFaz 1
  • University of Texas - MD Anderson Cancer Center, Houston
24 Months – 18 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT06441331

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Ap rekriteFaz 1/2
  • Crinetics Study Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07129252

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Ap rekriteFaz 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Houston
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT06805825

Etid Timò Nèwo-endokrin nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.